Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation
ESOGER
Socio-geriatric Evaluation (ESOGER): A Clinical Tool in Telehealth to Fight Against Vulnerable Seniors's Health Alterations and Social Isolation
1 other identifier
interventional
260
1 country
1
Brief Summary
With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2021
CompletedFirst Posted
Study publicly available on registry
September 30, 2021
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFebruary 23, 2024
February 1, 2024
3.2 years
September 21, 2021
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
COVID-19 symptoms
presence or not of fever, cough, and shortness of breath (binary question)
3 months
psychological fraility
Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious
3 months
Social health
Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)
3 months
Socio-economic characteristics
Presence or not of socio-economic problems (binary questions)
3 months
Participant's Quality of life
Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.
3 months
Autonomy
ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.
3 months
Secondary Outcomes (1)
Caregiver burden
3 months
Study Arms (2)
Group Intervention
EXPERIMENTALExperimental: Group 1 The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Group control
NO INTERVENTIONThe participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations
Interventions
Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP
Eligibility Criteria
You may qualify if:
- Aged 65 and more
- Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance
- Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.
You may not qualify if:
- Principal address outside of the CCSMTL's Jeanne-Mance territory
- Participate at another clinical trial, to avoid interferences
- Not understand written or spoken French or English, questionnaires are only available in French and English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CRIUGM
Montreal, Quebec, H3W 1W5, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Senior researcher, Director of laboratory
Study Record Dates
First Submitted
September 21, 2021
First Posted
September 30, 2021
Study Start
April 4, 2022
Primary Completion
June 1, 2025
Study Completion
March 1, 2026
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share